Covid-19 roundup: Biden invests $1.7B to address Covid variants; EU puts faith in Pfizer with new vaccine deals

Nicole DeFeudis

Editor

Zachary Brennan

Senior Editor

The Biden administration said Friday that it’ll pump $1.7 billion into various programs to address Covid-19 variants as the original strain of Covid-19 makes up …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: Biden invests $1.7B to address Covid variants; EU puts faith in Pfizer with new vaccine deals

Nicole DeFeudis

Editor

Zachary Brennan

Senior Editor

Sign up to read this article for free.

WuXi AppTec will sell cell and gene therapy business to private equity firm

The Endpoints 2024 winners and losers list: Who was up and who was down in biopharma

CMS explains what went into its first round of drug price negotiations

CagriSema’s weight loss data disappointed. What does Novo do next?

Vertex gets 'vanza triple' approval and Trikafta expansion — with boxed warnings

Novo Nordisk’s once-daily hemophilia drug Alhemo approved in US

Covid-19 roundup: Biden in­vests $1.7B to ad­dress Covid vari­ants; EU puts faith in Pfiz­er with new vac­cine deals

Editor

Senior Editor

Sign up to read this article for free.

more like this

Covid-19 roundup: Biden invests $1.7B to address Covid variants; EU puts faith in Pfizer with new vaccine deals